Novartis pumps $7.5M into push to save 100,000 lives from prostate cancer by 2035
Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero Prostate Cancer’s Blitz the Barriers, a project designed to address disparities in health outcomes for prostate cancer patients.
Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero Prostate Cancer’s Blitz the Barriers, a project designed to address disparities in health outcomes for prostate cancer patients.
